Skip to content
The Policy VaultThe Policy Vault

Romvimza (vimseltinib) — Medica

Tenosynovial giant cell tumor (Pigmented villonodular synovitis)

Initial criteria

  • patient is age ≥ 18 years
  • the tumor is not amenable to improvement with surgery

Approval duration

1 year